Skip to content

Clinical trials

Thrombocytopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Clear all

407 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20027
20038
20044
200518
200614
20077
200811
200918
201019
201114
201215
201318
201420
201514
201612
201712
201821
201920
202017
202121
202217
202323
202415
202528
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed212
Unknown status62
Terminated54
Recruiting39
Withdrawn14
Not yet recruiting14
Active, not recruiting8
Enrolling by invitation2
No longer available1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline20
Amgen19
National Heart, Lung, and Blood Institute (NHLBI)14
M.D. Anderson Cancer Center10
Shandong University9
Novartis Pharmaceuticals7
Peking University People's Hospital6
Eisai Inc.5
Institute of Hematology & Blood Diseases Hospital, China5
Memorial Sloan Kettering Cancer Center5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia407
Purpura, Thrombocytopenic, Idiopathic51
Anemia39
Neutropenia29
Hematologic Diseases26
Hemorrhage26
Myelodysplastic Syndromes25
Anemia, Aplastic19
Autoimmune Diseases14
Hematologic Neoplasms14

Trials

Showing 51 to 75 of 407. Each trial links to its page on Pharma Observatory.

307 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.